The first Theravance Biopharma trade was made in Q4 2014.
Since then Jim Simons bought shares six more times and sold shares on six occasions. The investor sold all their shares in Q1 2023 and doesn't own any shares in Theravance Biopharma anymore.
Avg closing price
Price range
Sold -176 Thousand shares
Q1 2023
Avg closing price
$10.57
Price range
$9.87
-
$11.44
Increased shares by 15.9% (+24.2 Thousand shares)
Q4 2022